menu
    • menu

    Company profile for Revive Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Revive Therapeutics Ltd. (CSE: RVV) is a cannabis life sciences company focused on the research, development, and commercialization of novel cannabinoid-based products. The Company’s novel cannabinoid delivery technology is being advanced to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory and liver disea...
    Revive Therapeutics Ltd. (CSE: RVV) is a cannabis life sciences company focused on the research, development, and commercialization of novel cannabinoid-based products. The Company’s novel cannabinoid delivery technology is being advanced to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory and liver diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Revive TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    82 Richmond Street East Toronto, Ontario M5C 1P1
    Telephone
    Telephone
    905-605-5535
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://revivethera.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Revive Therapeutics Updates Nerve Agent Countermeasure Study
    Revive Therapeutics Updates Nerve Agent Countermeasure Study

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192926/0/en/Revive-Therapeutics-Provides-Update-of-Key-Nerve-Agent-Countermeasure-Study.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share
    Revive Therapeutics Closes Second Tranche of Private Placement
    Revive Therapeutics Closes Second Tranche of Private Placement

    19 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/19/3153443/0/en/Revive-Therapeutics-Announces-Closing-of-Second-Tranche-of-Private-Placement.html

    GLOBENEWSWIRE
    19 Sep 2025
    Share Share
    Revive Therapeutics Extends Private Placement Proposal
    Revive Therapeutics Extends Private Placement Proposal

    05 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/05/3145577/0/en/Revive-Therapeutics-Announces-Extension-of-Proposed-Private-Placement.html

    GLOBENEWSWIRE
    05 Sep 2025
    Share Share
    Revive Therapeutics Closes First Tranche of Private Placement
    Revive Therapeutics Closes First Tranche of Private Placement

    11 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/11/3131368/0/en/Revive-Therapeutics-Announces-Closing-of-First-Tranche-of-Private-Placement-and-Debt-Settlement.html

    GLOBENEWSWIRE
    11 Aug 2025
    Share Share
    Revive Therapeutics Proposes Private Placement, Debt Settlement
    Revive Therapeutics Proposes Private Placement, Debt Settlement

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/31/3124605/0/en/Revive-Therapeutics-Announces-Proposed-Private-Placement-and-Debt-Settlement.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share
    Revive Therapeutics Completes Key Nerve Agent Study
    Revive Therapeutics Completes Key Nerve Agent Study

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/08/3112245/0/en/Revive-Therapeutics-Clarifies-Completion-of-Key-Nerve-Agent-Countermeasure-Study.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search